News

Here goes some nice category description. Good for SEO.

Immunomedics Halts Sacituzumab govitecan trial; GSK-Vir Biotech collaboration; INO-4800 DNA COVID-19 Vaccine; Pfizer Commits $ 40M for COVID-19;

Business Consultant, News, Pharma Consultant

Immunomedics discontinues its trial early – hopes for accelerated approval of Sacituzumab govitecan for mTNBC Immunomedics– a New...

Read More

Niacin fights Glioblastoma, iTeos nets $125M, Pandion reels in $80M, Brii, Chinese partner, FDA to speed up COVID-19 therapies.

Business Consultant, News, Pharma Consultant

Niacin might help in combating Glioblastoma  Glioblastomas are difficult to treat in part as the brain’s immune cells are stifled and...

Read More

FDA permits COVID-19 treatment, Roche’s antibiotics pact, Moderna’s vaccine, FDA permits Remdesivir, ReCode needs USD 80 Million

Business Consultant, News, Pharma Consultant

FDA permits COVID-19 treatments with blood from survivors The FDA revealed the convalescent plasma use that is derived from the donated...

Read More

Thermo’s investment; Biohaven’s vazegepant Phase III trial; Cumberland’s aid

Business Consultant, News, Pharma Consultant

Thermo Fisher Scientific has announced to invest a hefty amount worth USD 800 Million across pharma manufacturing and services. The company...

Read More

CAR-T in killing tumors; Amunix raises $73M; Autism findings in protein-targeted treatment

Business Consultant, News, Pharma Consultant

Killing brain tumors with the help of CAR-T CAR-T cell therapy is a technique which involves modifying patients’ T cells to aim...

Read More
Close